PLZ4-coated paclitaxel-loaded micelles (LP Therapeutics/Harvard Medical School)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePLZ4-coated paclitaxel-loaded micelles (LP Therapeutics/Harvard Medical School)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of California Davis
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of California DavisLeap Therapeutics IncHarvard Medical School
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A